FAMILIAL APOLIPOPROTEIN-E DEFICIENCY

[1] ANCHORS JM, 1985, CLIN RES, V33, pA165

[2] HIGH-DENSITY LIPOPROTEIN DISTRIBUTION - RESOLUTION AND DETERMINATION OF 3 MAJOR COMPONENTS IN A NORMAL POPULATION-SAMPLE [J]. ATHEROSCLEROSIS, 1978, 29 (02) : 161 - 179

[3] BASU SK, 1982, J BIOL CHEM, V257, P9788

[4] CHARACTERIZATION OF HUMAN HIGH-DENSITY LIPOPROTEINS BY GRADIENT GEL-ELECTROPHORESIS [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 665 (03) : 408 - 419

[5] RADIOIMMUNOASSAY STUDIES OF HUMAN APOLIPOPROTEIN-E [J]. JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (06) : 1240 - 1250

[6] APOLIPOPROTEIN-E ASSOCIATED WITH ASTROCYTIC GLIA OF THE CENTRAL NERVOUS-SYSTEM AND WITH NONMYELINATING GLIA OF THE PERIPHERAL NERVOUS-SYSTEM [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (04) : 1501 - 1513

[7] TYPE-III HYPERLIPOPROTEINEMIA - DIAGNOSIS, MOLECULAR DEFECTS, PATHOLOGY, AND TREATMENT [J]. ANNALS OF INTERNAL MEDICINE, 1983, 98 (05) : 623 - 640

[8] DOSIMETRY OF GENOTOXIC AGENTS AND DOSE-RESPONSE RELATIONSHIPS OF THEIR EFFECTS [J]. MUTATION RESEARCH, 1983, 123 (02): : 121 - 182

[9] FREDRICK.DS, 1967, NEW ENGL J MED, V276, P34, DOI 10.1056/NEJM196701052760107

[10] FAT TRANSPORT IN LIPOPROTEINS - AN INTEGRATED APPROACH TO MECHANISMS AND DISORDERS (CONCLUDED) [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (05) : 273 - +

[1] ANCHORS JM, 1985, CLIN RES, V33, pA165

[2] HIGH-DENSITY LIPOPROTEIN DISTRIBUTION - RESOLUTION AND DETERMINATION OF 3 MAJOR COMPONENTS IN A NORMAL POPULATION-SAMPLE [J]. ATHEROSCLEROSIS, 1978, 29 (02) : 161 - 179

[3] BASU SK, 1982, J BIOL CHEM, V257, P9788

[4] CHARACTERIZATION OF HUMAN HIGH-DENSITY LIPOPROTEINS BY GRADIENT GEL-ELECTROPHORESIS [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 665 (03) : 408 - 419

[5] RADIOIMMUNOASSAY STUDIES OF HUMAN APOLIPOPROTEIN-E [J]. JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (06) : 1240 - 1250

[6] APOLIPOPROTEIN-E ASSOCIATED WITH ASTROCYTIC GLIA OF THE CENTRAL NERVOUS-SYSTEM AND WITH NONMYELINATING GLIA OF THE PERIPHERAL NERVOUS-SYSTEM [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (04) : 1501 - 1513

[7] TYPE-III HYPERLIPOPROTEINEMIA - DIAGNOSIS, MOLECULAR DEFECTS, PATHOLOGY, AND TREATMENT [J]. ANNALS OF INTERNAL MEDICINE, 1983, 98 (05) : 623 - 640

[8] DOSIMETRY OF GENOTOXIC AGENTS AND DOSE-RESPONSE RELATIONSHIPS OF THEIR EFFECTS [J]. MUTATION RESEARCH, 1983, 123 (02): : 121 - 182

[9] FREDRICK.DS, 1967, NEW ENGL J MED, V276, P34, DOI 10.1056/NEJM196701052760107

[10] FAT TRANSPORT IN LIPOPROTEINS - AN INTEGRATED APPROACH TO MECHANISMS AND DISORDERS (CONCLUDED) [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (05) : 273 - +